NASH trials recruiting in Minnesota

All NASH trials nationally

Cities in Minnesota

Recruiting trials in Minnesota

• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
  NCT07165028 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Minnesota: Minneapolis
• A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
  NCT06528314 · Phase: Phase 3 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Minnesota: Rochester
• A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
  NCT06318169 · Phase: Phase 3 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Minnesota: Maplewood, Rochester
• A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
  NCT06419374 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Minnesota: Minneapolis, Rochester
• Fibrosis Lessens After Metabolic Surgery
  NCT06374875 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Minnesota: Rochester
• LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
  NCT06632457 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Minnesota: Minneapolis
• LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
  NCT06632444 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Minnesota: Minneapolis
• Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
  NCT05832229 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Minnesota: Rochester
• Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced Fibrosis
  NCT05720663 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Minnesota: Rochester
• The Olmsted NAFLD Epidemiology Study (TONES)
  NCT04365855 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Minnesota: Rochester
• Vertical Sleeve Gastrectomy and Lifestyle Modification for the Treatment of Non-Alcoholic Steatohepatitis
  NCT03587831 · Phase: Not applicable (e.g. observational or device study) · Ages: 30 Years to 70 Years · Sex: All (male and female) · Minnesota: Minneapolis